Disease onset was typically later in patients with DNAJB2 variants (late adolescence or early adulthood) compared to patients with HINT1 variants (childhood or early adolescence), yet patients with DNAJB2 variants more frequently developed severe neuropathy, as reflected by higher CMTNS scores. This evidence concerns the gene DNAJB2 and neuropathy.